How to treat mania

狂躁 奎硫平 齐拉西酮 阿塞那平 奥氮平 双相情感障碍 精神科 心理学 拉莫三嗪 心情 医学 双峰 利培酮 心理教育 情绪稳定器 精神分裂症(面向对象编程) 心理干预 癫痫
作者
Isabella Pacchiarotti,Gerard Anmella,Lluc Colomer,Eduard Vieta
出处
期刊:Acta Psychiatrica Scandinavica [Wiley]
卷期号:142 (3): 173-192 被引量:32
标识
DOI:10.1111/acps.13209
摘要

In this paper, we aimed at reviewing evidence-based treatment options for bipolar mania and proposed tentative evidence-based clinical suggestions regarding the management of a manic episode, especially regarding the choice of the proper mood stabilizer and antipsychotic medication.A narrative review was undertaken addressing 'treatment of bipolar mania'. Findings have been synthesized and incorporated with clinical experience into a model to support different treatment choices.To date, there is solid evidence supporting the use of several medications, such as lithium, divalproex, and carbamazepine, and antipsychotics, such as chlorpromazine, haloperidol, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole, inhaled loxapine, asenapine, and cariprazine in acute mania, and some evidence supporting the use of clozapine or electroconvulsive therapy in treatment-refractory cases. However, in clinical practice, when making decisions about treatment, personalized treatment is needed, according to the different clinical presentations and more complex clinical situations within the manic episode and considering a long-term view and with the objective of not only a symptomatic but also functional recovery. After remission from acute mania, psychoeducation strategies are useful to ensure adherence.Despite the evidence forefficacy of many currently available treatments for mania, the majority of RCTs provide little direction for the clinician as to what steps might be optimal in different presentations of mania as well as in the presence of specific patient characteristics. Manic episodes should be managed on a personalized basis considering the clinical course and patient criteria and with the expectation of maintaining that treatment in the long-term.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1900完成签到,获得积分10
1秒前
1秒前
纯真紫伊发布了新的文献求助10
1秒前
NexusExplorer应助JUZI采纳,获得10
1秒前
星空完成签到,获得积分10
1秒前
2秒前
斯文败类应助crzgogo采纳,获得10
3秒前
学霸业应助萝卜大王采纳,获得10
4秒前
zzz完成签到,获得积分10
4秒前
小陈应助西西采纳,获得10
4秒前
4秒前
LuciusHe完成签到,获得积分10
5秒前
田様应助tangweidong采纳,获得10
5秒前
怕黑的钥匙完成签到,获得积分10
5秒前
X_RAIN完成签到,获得积分10
5秒前
明明如月完成签到,获得积分20
5秒前
Mrs.yang发布了新的文献求助50
5秒前
机智珠发布了新的文献求助10
6秒前
pyx188发布了新的文献求助10
6秒前
wanci应助Levonpox采纳,获得10
6秒前
DownTAT发布了新的文献求助30
6秒前
ggg完成签到 ,获得积分10
7秒前
7秒前
777发布了新的文献求助200
7秒前
林夕应助今夜不再打游戏采纳,获得10
7秒前
7秒前
catchick发布了新的文献求助10
8秒前
ZhSh完成签到,获得积分10
8秒前
英姑应助学习猴采纳,获得10
8秒前
8秒前
明明如月发布了新的文献求助10
8秒前
Eden应助水个水凝胶采纳,获得20
9秒前
9秒前
9秒前
李健的小迷弟应助tangz采纳,获得10
9秒前
盘挞完成签到,获得积分10
9秒前
9秒前
pan完成签到,获得积分10
9秒前
Levonpox完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
Resiliency Scale for Adolescents--Chinese Version 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7326517
求助须知:如何正确求助?哪些是违规求助? 8941527
关于积分的说明 18962249
捐赠科研通 6982589
什么是DOI,文献DOI怎么找? 3215818
关于科研通互助平台的介绍 2382890
邀请新用户注册赠送积分活动 2195193